Aspirin and cancer: the emerging evidence

Trial participants who took a low-dose aspirin daily were no more likely to be diagnosed with cancer than those who took a placebo. But they did have a moderately higher risk of being diagnosed with advanced cancer and were more likely to die from advanced cancer.


 

Online statistics

Members online
10
Guests online
164
Total visitors
174

Latest posts

Back
Top